
Health officials on the Island seeing increased demand for measles vaccine
Social Sharing
While there are no cases of measles on Prince Edward Island, and haven't been any for 12 years, the province's Chief Public Health Office is encouraging people to get the vaccinated — especially if they plan to travel.
Islanders seem to be doing their part to keep a lid on the disease, with public health nursing seeing an increase in the number of people asking for the vaccine.
"Two doses of this vaccine, it's 98 per cent effective. It's really good," said Dr. Heather Morrison, P.E.I.'s chief public health officer.
"The recommendation is really if you're [doing] air travel or driving to places that may have measles, including Quebec and Ontario… it's really important to get vaccinated."
Immunizations for measles, mumps and rubella are free and available through public health nursing. People interested in getting the vaccine can check its availability on the province's website.
Islanders urged to seeks shots as P.E.I. manages to stay measles-free, for now
4 hours ago
Duration 2:03
Demand for the measles vaccine is up on Prince Edward Island. There are still no cases in the province, but with the virus on the rise in other parts of North America, the chief public health office says preparation is key. CBC's Sheehan Desjardins explains.
There have been no measles cases on P.E.I. since 2013, but health officials are monitoring the situation elsewhere in the country.
Toronto Public Health recently warned residents in the city that they could be in danger of measles exposure. Last Tuesday, 14 cases were reported in the Region of Waterloo, Ont., just a few weeks after the area confirmed its first case.
"This is a disease that we really have seen very little of in North America," Morrison said.
"There have been young people who have had serious outcomes south of the border, but also hospitalizations in Ontario, for instance, particularly with young children."
As of Monday, two unvaccinated children had died of complications related to measles in Texas, where at least 500 people were confirmed to have been infected in recent weeks.
What to watch for
Measles symptoms can include fever, runny nose, cough, red eyes, a red rash that begins on the face and spreads down the body, and small blueish-white spots on the inside of the mouth and throat.
The incubation period for the virus can be up to 21 days, said Morrison, but symptoms can also appear within 12 days of exposure.
Most Canadian children are vaccinated against measles when they're one year old, then again at 18 months. Public health will vaccinate infants early, between six months to a year, if their parents plan to travel with them.
Many adults born before 1970 are considered to have a natural immunity to the virus, but Morrison said they should still get one dose of the vaccine before travelling this year.
With so many people travelling at this time of year, Morrison said it's important to be vigilant in case measles hitches a ride back to P.E.I. with someone.
"There are certain populations here that are at risk because they're not vaccinated," she said. "Trying to make sure that we work with these communities and individuals and answer questions and get the information out as best we can is going to be something that's important for us."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
an hour ago
- Cision Canada
AURORA CANNABIS CHS CLASS ACTION CERTIFIED
TORONTO, June 9, 2025 /CNW/ - Thousands of Canadian cannabis users are hospitalized and diagnosed with Cannabinoid Hyperemesis Syndrome ("CHS") every year. CHS is a dangerous side effect that can develop from the regular use of cannabis products. CHS involves cyclical bouts of severe nausea, vomiting, and abdominal pain, which can persist for days and can occur as often as once every five minutes. In extreme cases, CHS can result in organ failure and even death. On May 14, 2025, the Ontario Superior Court of Justice certified a national class action which alleges that Aurora Cannabis Inc, and Aurora Cannabis Enterprises Inc. negligently failed to warn consumers of the risk of developing CHS posed by the regular use of their cannabis products. This means that the action can now proceed as a class action. No findings of liability have been made against the defendants. The action was commenced by V.T., a Canadian Forces veteran who was prescribed cannabis to treat medical conditions. V.T. purchased medicinal cannabis from the Defendants, and used it as prescribed, until they suffered two extreme bouts of nausea, vomiting and abdominal pain that were so severe V.T. had to be hospitalized. On the second E.R. visit, V.T. was diagnosed as suffering from CHS. The only certain cure for CHS is to stop consuming cannabis, which V.T. did, and is now symptom-free. None of the cannabis products that V.T. consumed contained any warning about CHS, nor is there any warning in the product monograph, or on Aurora's website. The claim alleges that the Defendants knew, or should have known, of the risk of CHS arising from the regular use of their cannabis products, but negligently failed to provide any warning to consumers or prescribing physicians about the risk that they could develop CHS. The class action seeks to recover damages for the Class Members who developed CHS. The class action is brought on behalf of all persons in Canada who purchased a Cannabis Product from Aurora Cannabis Inc. or Aurora Cannabis Enterprises Inc. (which includes MedReleaf) on or after February 1, 2014 to May 14, 2025 (the "Class Period") who were diagnosed or differentially diagnosed with CHS during the Class Period after consuming one or more Cannabis Products. Cannabis Products are the cannabis and/or synthetic cannabinoid resins, pills, lozenges, concentrates, oils, edibles, beverages, vapours, and raw and adulterated plant material cultivated, designed, manufactured, packaged, labeled, distributed, marketed, and/or sold by the Defendants. The allegations contained in the Fresh as Amended Statement of Claim have not been proven in court, and the Defendants deny the Plaintiff's claims. . Sotos Class Actions 55 University Avenue, Suite 600 Toronto, ON M5J 2H7 [email protected] 1-877-294-9747 (toll free) For media inquiries, please contact Margaret Waddell by phone at 416.977.2413 or by email at [email protected].


Calgary Herald
2 hours ago
- Calgary Herald
Opinion: What does it mean to be Albertan in Canada? Lessons from refugee resettlement
In uncertain times, it's easy to become consumed by anxiety, anger and division. But these moments are precisely when we must reflect on our core values and ask: What does it mean to be Albertan or Canadian? For us, as physicians at the Calgary Refugee Health Clinic, the answers lie not in the loudest voices but in our patients' quiet resilience. Since 2011, our clinic has cared for over 15,000 refugees. Their stories and Alberta's welcome reveal the best of who we are. Article content Article content Calgary serves as Canada's western hub for refugee resettlement thanks to effective settlement and clinical programs developed over decades of inter-jurisdictional collaboration. Since the 2021 Afghan Resettlement Initiative, thousands of Afghan and other displaced families have arrived. Working with settlement agencies like CCIS, we often received only 24 to 48 hours' notice. We would meet at the airport with urgent medical care, warmth, and services. This reflects a rare but effective partnership between federally funded settlement agencies and provincially funded health services. Article content Article content This partnership isn't just functional, it's exemplary. Alberta leads Canada in refugee resettlement. And no municipality in Canada – among the 55 we examined – resettles more refugees per capita than Brook, a prairie town an hour from Medicine Hat. Article content Article content When we share these stories in academic and international circles through our work with the World Health Organization and UN Refugee Agency (UNHCR), we're often met with disbelief. Canada's 'most conservative province' is also its most welcoming? We've just returned from Geneva, co-organizing a high-level side event for the WHO's 78th World Health Assembly. From this global perspective, we've learned what sounds like a most un-Canadian boast: Canada is exceptionally good at refugee resettlement and multicultural integration. Few Canadians know we are the only nation awarded the UNHCR's Nansen Refugee Award, for our response to the 1970s and 80s Indochinese refugee crisis, when Canada invented the Private Refugee Sponsorship Program, now emulated worldwide. Canada has since pioneered multiple resettlement programs, including Ugandan Ismailis, Central and South Americans, South Sudanese, Kosovars, Syrians, Afghans and Ukrainians.


Cision Canada
7 hours ago
- Cision Canada
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care Français
TORONTO, June 9, 2025 /CNW/ - Sanofi Canada today announced the appointment of James Guy as Country Lead, Canada and General Manager, Specialty Care. In this role, Guy will lead Sanofi's Canada Country Council, which manages the operations of the company's three business units and functions. Guy will also head the Specialty Care business unit in Canada. Country Lead, Canada and General Manager, Specialty Care "This is an exciting time in Sanofi's history, with the potential for our promising pipeline to deliver several scientific breakthroughs that can improve healthcare around the globe. The company is building on this momentum, leveraging next-gen technology and AI, to turn breakthrough science into reality for patients. I feel privileged to be back home in Canada working with our talented teams; I'm confident that their patient-focused approach will deliver new solutions that will continue to benefit Canadian patients." Guy brings over two decades of pharmaceutical industry experience, including 13 years with Sanofi in global, US, and Canadian leadership roles, most recently as the Immunology Franchise Head in Canada. His prior positions within Sanofi include International Strategic Marketing Director based in the Czech Republic, Respiratory Global Brand Lead based in the US, and Regional Business Director in the US affiliate. A Canadian citizen, Guy holds a in Applied Chemistry & Biology from Toronto Metropolitan University, an in Biomedical Sciences from the University of Bradford (UK), and an MBA from Rutgers University (USA). With over 2,000 employees across the country, Sanofi's operations in Canada include R&D, Commercial, the country's largest biomanufacturing facility, and an AI Centre of Excellence. The company is uniquely positioned to deliver across the full life sciences value chain within Canada. As Country Lead, Guy will chair the Canada Country Council, which includes: About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. In Canada, we employ over 2,000 people and invest 20% of our revenue annually in biopharma research, representing $1.2 billion CAD in R&D over the last decade, creating jobs, business, and opportunity throughout the country. We are the largest biomanufacturing facility in Canada and are on track to deliver over $2 billion in new infrastructure investments by 2028, including two new vaccine manufacturing facilities at our Toronto Campus. For more than 110 years, we have been working in collaborative partnerships with a vast network of healthcare stakeholders and are committed to creating a healthier future in Canada.